Results 11 to 20 of about 178,030 (50)

The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels

open access: yesCancer Medicine, 2022
Background Liver cancer is one of the most common cancers worldwide. We aimed to report the burden of liver cancer at the global, regional, and national levels in 204 countries from 1990 to 2019, stratified by etiology, sex, age, and sociodemographic ...
Jianqing Yang   +9 more
doaj   +1 more source

AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study

open access: yesFrontiers in Oncology, 2022
BackgroundAldo-keto reductase 1B10 (AKR1B10) is a secretory protein that is upregulated in breast cancer.ObjectiveThis case-controlled pilot study evaluated the serum level of AKR1B10 in healthy women and patients with a localized or metastatic breast ...
Zhe Cao   +13 more
doaj   +1 more source

BCAT1: A risk factor in multiple cancers based on a pan‐cancer analysis

open access: yesCancer Medicine, 2022
Background Although branched chain amino acid transaminase 1 (BCAT1) has been identified to play an essential role in multiple tumors, no studies on its role in pan‐cancer have been consulted before.
Guo‐Sheng Li   +8 more
doaj   +1 more source

Please Place Your Seat in the Full Upright Position: A Technical Framework for Landing Upright Radiation Therapy in the 21st Century

open access: yesFrontiers in Oncology, 2022
Delivering radiotherapy to patients in an upright position can allow for increased patient comfort, reduction in normal tissue irradiation, or reduction of machine size and complexity.
Sarah Hegarty   +16 more
doaj   +1 more source

Characterization of m6A regulator‐mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia

open access: yesCancer Medicine, 2022
Background Previous studies have confirmed the existence of epigenetic regulation of immune responses in acute myeloid leukemia. However, the potential role of RNA N6‐methyladenosine (m6A) remodeling in tumor microenvironment (TME) infiltration remains ...
Shiyu Han   +6 more
doaj   +1 more source

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma

open access: yesFrontiers in Oncology, 2022
Pyroptosis is an inflammatory form of programmed cell death that is involved in various cancers, including hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs) were recently verified as crucial mediators in the regulation of pyroptosis. However,
Ze-Kun Liu   +14 more
doaj   +1 more source

The Cell Cycle-Associated Protein CDKN2A May Promotes Colorectal Cancer Cell Metastasis by Inducing Epithelial-Mesenchymal Transition

open access: yesFrontiers in Oncology, 2022
Colorectal cancer (CRC) is a common gastrointestinal malignancy, and recurrence and metastasis contribute considerably to its high mortality. It is well known that the epithelial-mesenchymal transition (EMT) accelerates the rate of cancer cell ...
Wei-Kun Shi   +3 more
doaj   +1 more source

Psychological Distress, Coping Strategies, and Quality of Life in Breast Cancer Patients Under Neoadjuvant Therapy: Protocol of a Systematic Review

open access: yesCancer Control, 2022
Introduction Women with breast cancer eligible for neoadjuvant therapy (NAT) present a disorder of biopsychosocial variables and alteration of their quality of life.
Majid Omari MPH   +8 more
doaj   +1 more source

Potential Role of APEX1 During Ferroptosis

open access: yesFrontiers in Oncology, 2022
Ferroptosis is a recently discovered category of programmed cell death. It is much different from other types of cell death such as apoptosis, necrosis and autophagy.
Nan Guo   +5 more
doaj   +1 more source

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study

open access: yesFrontiers in Oncology, 2022
Treatment-free remission (TFR) has become a primary therapeutic goal in CML and is also considered feasible by international guidelines. TKIs dose reduction is often used in real-life practice to reduce adverse events, although its impact on TFR is still
Alessandra Iurlo   +27 more
doaj   +1 more source

Home - About - Disclaimer - Privacy